Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Denise Kruse: So your startup wants to be acquired – now what?
Editor’s note: The opinions expressed in this commentary are the author’s alone. In the first column this three-part series, I discussed how a stellar strategy only gets your company halfway, but executing can take you to the finish line. Next, we took a deep dive into what startups should do after landing a first big…
Tech tracks workplace bias: It exists ‘whether you want to face it or not’
During a summer internship with a large Kansas City corporation, college student Louis Byrd was unexpectedly called into the HR office. Although the incident was about 10 years ago today, it has not yet left his mind, Byrd said. “I’ll never forget this,” he said. “HR told me that the people on my team had…
EyeVerify explains why it changed name to Zoloz
More than two months after revealing a curious name change, EyeVerify is offering details behind its evolution to become “Zoloz.” The fast-growing biometrics tech firm announced in August that it was rebranding as Zoloz, but initially offered little information about the reason for or meaning behind the name change. Headquartered in downtown Kansas City, a…
Sandy Kemper-led YEP KC primes teen entrepreneurs for success
If all extraordinary students knew they were exceptional, the world would be a much more entrepreneurial place, said Sandy Kemper. “It’s the future of our city,” said Kemper, co-founder of YEP KC, about young talent. “If we can capture them early, before they go to college, we can create a network that can sustain them…